PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jrsocmedLink to Publisher's site
 
J R Soc Med. 1986 August; 79(8): 460–461.
PMCID: PMC1290416

Trial of (+)-cyanidanol-3 in patients with hepatitis B chronic liver disease.

Abstract

A double-blind controlled trial of 12 months' treatment with (+)-cyanidanol-3 was carried out in 26 patients with chronic hepatitis B liver disease. Treatment did not improve liver blood tests nor histological appearances of the liver, but there was a trend towards reduction of serum titres of hepatitis B surface antigen.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (341K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
 
 

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Schalm SW, Heytink RA, van Buuren HR, de Man RA. Acyclovir enhances the antiviral effect of interferon in chronic hepatitis B. Lancet. 1985 Aug 17;2(8451):358–360. [PubMed]
  • Sagnelli E, Piccinino F, Manzillo G, Felaco FM, Filippini P, Maio G, Pasquale G, Izzo CM. Effect of immunosuppressive therapy on HBsAg-positive chronic active hepatitis in relation to presence or absence of HBeAg and anti-HBe. Hepatology. 1983 Sep-Oct;3(5):690–695. [PubMed]
  • Blum AL, Berthet P, Doelle W, Goebell H, Kortüm K, Pelloni S, Peter P, Poulsen H, Strohmeyer G, Tygstrup N. Treatment of acute viral hepatitis with (+)-cyanidanol-3. Lancet. 1977 Dec 3;2(8049):1153–1155. [PubMed]
  • Schomerus H, Wiedmann KH, Dölle W, Peerenboom H, Strohmeyer G, Balzer K, Goebell H, Dürr HK, Bode C, Blum AL, et al. (+)-Cyanidanol-3 in the treatment of acute viral hepatitis: a randomized controlled trial. Hepatology. 1984 Mar-Apr;4(2):331–335. [PubMed]
  • Pár A, Paál M, Kádas I, Kerekes E, Jávor T. Effect of (+)-cyanidanol-3 (Catergen) in chronic active hepatitis. (Catergen plus prednisolone versus prednisolone in a controlled study). Acta Med Hung. 1983;40(1):17–24. [PubMed]
  • Bar-Meir S, Halpern Z, Gutman M, Shpirer Z, Baratz M, Bass D. Effect of (+)-cyanidanol-3 on chronic active hepatitis: a double blind controlled trial. Gut. 1985 Sep;26(9):975–979. [PMC free article] [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press